ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD245 Antibody [DY12] (PE) (A320705)

Mouse monoclonal [DY12] antibody to CD245 (PE) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-CD245 Antibody [DY12] (PE)
Description
Mouse monoclonal [DY12] antibody to CD245 (PE).
Specificity
This antibody recognizes an extracellular epitope of CD245, a transmembrane protein expressed mainly by peripheral blood lymphocytes, NK cells, monocytes, granulocytes and platelets.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: The reagent is designed for analysis of human blood cells using 10 µl reagent / 100 µl of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Reactivity
Human
Immunogen
Human NK-type YT2C2 cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
DY12
Isotype
IgG1
Light Chains
kappa
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
This antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Synonyms
KIAA0216, MAJN, Molecule associated with JAK3 N-terminus, Myosin containing a PDZ domain, MYSPDZ, SP-R210, Surfactant protein receptor SP-R210, TIAF1, Unconventional myosin-XVIIIa
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD245 Antibody [DY12] (PE) (A320705)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with MYO18A

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
97.1% Relevancy Score
89.2% Relevancy Score
87.1% Relevancy Score
86.9% Relevancy Score
85.8% Relevancy Score
83.8% Relevancy Score
83.3% Relevancy Score
79.8% Relevancy Score
75.7% Relevancy Score